Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 6, 2003, Pages 895-901

  Natori, Shunsuke ^b   Hasebe, Naoyuki ^a   Jin, Yin Tie ^b   Matsusaka, Tomoyuki ^b   Ido, Akira ^b   Matsuhashi, Hironobu ^b   Ihara, Tadashi ^b   Kikuchi, Kenjiro ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

Heart failure; Hemodynamics; Nitric oxide; Q ; Vasodilation

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; GLYCERYL TRINITRATE; ISOPRENALINE; NITRIC OXIDE; NORADRENALIN; PROCAINAMIDE; VASOACTIVE AGENT; ANGIOTENSIN II; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART PRELOAD; HEART STRESS; HEART VENTRICLE ENDDIASTOLIC PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; SYSTOLE; ANIMAL; CHEMICALLY INDUCED DISORDER; CONGESTIVE HEART FAILURE; DIASTOLE; DISEASE MODEL; DRUG SCREENING; HEART STROKE VOLUME; HEMODYNAMICS; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG CIRCULATION; PATHOPHYSIOLOGY; RANDOMIZATION; VASCULAR RESISTANCE;

ACETYLCHOLINE; ADMINISTRATION, INHALATION; ANGIOTENSIN II; ANIMALS; DIASTOLE; DISEASE MODELS, ANIMAL; DOGS; DRUG EVALUATION, PRECLINICAL; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; ISOPROTERENOL; MALE; NITRIC OXIDE; NITROGLYCERIN; NOREPINEPHRINE; PROCAINAMIDE; PULMONARY CIRCULATION; RANDOM ALLOCATION; STROKE VOLUME; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0037445162     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200201-057OC     Document Type: Article

References (39)

1. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1978;61:866-879.
2. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.
3. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
4. Paulus WJ, Vantrimpont PJ, Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 1995;92:2119-2126.
5. Michel T, Smith TW. Nitric oxide synthases and cardiovascular signaling. Am J Cardiol 1993;72:33C-38C.
6. Hare JM, Colucci WS. Role of nitric oxide in the regulation of myocardial function. Prog Cardiovasc Dis 1995;38:155-166.
7. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-2047.
8. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990;66:1561-1575.
9. Rimar S, Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 1993;88:2884-2887.
10. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818-819.
11. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-820.
12. Pepke Zaba J, Higenbottam TW, Dinh Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-1174.
13. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
14. Roberts JD Jr, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993;87:447-453.
15. Girard C, Lehot JJ, Pannetier JC, Filley S, Ffrench P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77:880-883.
16. Okabayashi K, Triantafillou AN, Yamashita M, Aoe M, DeMeester SR, Cooper JD, Patterson GA. Inhaled nitric oxide improves lung allograft function after prolonged storage. J Thorac Cardiovasc Surg 1996;112:293-299.
17. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994;90:2780-2785.
18. Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, Fifer MA. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24:982-988.
19. Koelling TM, Kirmse M, Di Salvo TG, Dec GW, Zapol WM, Semigran MJ. Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction. Am J Cardiol 1998;81:1494-1497.
20. Bocchi EA, Bacal F, Auler Junior JO, Carmone MJ, Bellotti G, Pileggi F. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol 1994;74:70-72.
21. Hayward CS, Rogers P, Keogh AM, Kelly R, Spratt PM, Macdonald PS. Inhaled nitric oxide in cardiac failure: vascular versus ventricular effects. J Cardiovasc Pharmacol 1996;27:80-85.
22. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993;91:2314-2319.
23. Brady AJ, Warren JB, Poole Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993;265:H176-H182.
24. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389.
25. de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S. Nitric oxide synthase activities in human myocardium. Lancet 1993;341:84-85.
26. Brady AJ, Poole Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992;263:H1963-H1966.
27. Avontuur JA, Bruining HA, Ince C. Sepsis and nitric oxide. Adv Exp Med Biol 1996;388:551-567.
28. Afulukwe IF, Cohen RI, Zeballos GA, Iqbal M, Scharf SM. Selective NOS inhibition restores myocardial contractility in endotoxemic rats; however, myocardial NO content does not correlate with myocardial dysfunction. Am J Respir Crit Care Med 2000;162:21-26.
29. Hayward CS, Kalnins WV, Rogers P, Feneley MP, MacDonald PS, Kelly RP. Effect of inhaled nitric oxide on normal human left ventricular function. J Am Coll Cardiol 1997;30:49-56.
30. Goldstein DJ, Dean DA, Smerling A, Oz MC, Burkhoff D, Dickstein ML. Inhaled nitric oxide is not a negative inotropic agent in a porcine model of pulmonary hypertension. J Thorac Cardiovasc Surg 1997;114:461-466.
31. Alousi AA, Canter JM, Fort DJ. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog. Cardiovasc Res 1985;19:483-494.
32. Matsubara H, Takaki M, Yasuhara S, Araki J, Suga H. Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle: better alternative to exponential time constant. Circulation 1995;92:2318-2326.
33. Senzaki H, Fetics B, Chen CH, Kass DA. Comparison of ventricular pressure relaxation assessments in human heart failure: quantitative influence on load and drug sensitivity analysis. J Am Coll Cardiol 1999;34:1529-1536.
34. Yin FC. Ventricular wall stress. Circ Res 1981;49:829-842.
35. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995;92:2198-2203.
36. Hasebe N, Natori S, Yen-Tie J, Matsusaka T, Kikuchi K. Inhaled nitric oxide attenuates endothelium dependent pulmonary vascular response and paradoxically enhances left ventricular contraction. Circulation 1998;98:I-141.
37. Armstrong PW, Walker DC, Burton JR, Parker JO. Vasodilator therapy in acute myocardial infarction: a comparison of sodium nitroprusside and nitroglycerin. Circulation 1975;52:1118-1122.
38. Hare JM, Shernan SK, Body SC, Graydon E, Colucci WS, Couper GS. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance. Circulation 1997;95:2250-2253.
39. Jeffery C, Annick L, Michael O', Sangeeta B, Anne P, Hall JB. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 2000;161:1443-1449.